Market OverviewThe Global Hormone Replacement Therapy Market is valued at USD 22.6 Billion in 2023 and is projected to reach ...

The clue really is in the name with this one, with them simply being small, round patches that you stick on your arm ...

Aveva Drug Delivery systems (A DifGen company), a leader in transdermal drug delivery systems based out of Miramar - Florida is proud to announce the launch of all strengths of its generic Fentanyl ...

Prostate-specific antigen responses were similar between transdermal estradiol and hormone therapy combined with androgen ...

Responses were similar among patients with estrogen patches and ARPIs compared to luteinizing hormone releasing hormone ...

With 90% of the U.S. population living within 10 miles of a Walmart store, recalls of products they sell can have widespread ...

Aversa Fentanyl holds the potential to become the world’s first abuse-deterrent opioid patch.

ORLANDO - Nutriband Inc. (NASDAQ:NTRB), a developer of transdermal pharmaceutical products, has announced an exclusive partnership with Kindeva Drug Delivery to develop Aversa™ Fentanyl, a potential ...

Nutriband and Kindeva formalize exclusive product development partnership and long-term commitment based on shared development costs in exchange ...

Prostate cancer cells usually require male androgen hormones, such as testosterone, to grow. Androgen deprivation therapy ...